Ormaasen V - Search Results

1

Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.

Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K. Kvale D, et al. Among authors: ormaasen v. AIDS. 2006 Apr 4;20(6):813-20. doi: 10.1097/01.aids.0000218544.54586.f1. AIDS. 2006. PMID: 16549964 Clinical Trial.

2

[Antiviral therapy of HIV infection in adults].

Ormaasen V, Bruun JN. Ormaasen V, et al. Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3414-20. Tidsskr Nor Laegeforen. 2001. PMID: 11826789 Review. Norwegian.

3

A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA.

Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI. Ormaasen V, et al. Scand J Infect Dis. 2002;34(12):910-7. doi: 10.1080/0036554021000026957. Scand J Infect Dis. 2002. PMID: 12587624 Clinical Trial.

4

Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.

Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI. Ormaasen V, et al. Scand J Infect Dis. 2003;35(6-7):383-8. doi: 10.1080/00365540310009716. Scand J Infect Dis. 2003. PMID: 12953949 Clinical Trial.

5

An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy.

Ormaasen V, Sandvik L, Asjø B, Holberg-Petersen M, Gaarder PI, Bruun JN. Ormaasen V, et al. HIV Med. 2004 Nov;5(6):400-6. doi: 10.1111/j.1468-1293.2004.00244.x. HIV Med. 2004. PMID: 15544691 Free article.

6

Serum concentrations of protease inhibitors as predictors of HIV-related clinical events in patients on antiretroviral therapy.

Ormaasen V, Sandvik L, Rudberg N, Bruun JN. Ormaasen V, et al. Scand J Infect Dis. 2006;38(8):650-3. doi: 10.1080/00365540600616993. Scand J Infect Dis. 2006. PMID: 16857610

7

Ormaasen V, Sandvik L, Dudman SG, Bruun JN. Ormaasen V, et al. Scand J Infect Dis. 2007;39(1):51-7. doi: 10.1080/00365540600904779. Scand J Infect Dis. 2007. PMID: 17366013

8

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. Monforte Ad, et al. AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77. AIDS. 2008. PMID: 18832878 Free PMC article.

9

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Antiretroviral Therapy Cohort Collaboration (ART-CC); Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA. Antiretroviral Therapy Cohort Collaboration (ART-CC), et al. AIDS. 2008 Nov 30;22(18):2481-92. doi: 10.1097/QAD.0b013e328318f130. AIDS. 2008. PMID: 19005271 Free PMC article.

10

Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital.

Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN. Bratholm C, et al. Among authors: ormaasen v. J Antimicrob Chemother. 2010 Sep;65(9):1996-2000. doi: 10.1093/jac/dkq234. Epub 2010 Jun 24. J Antimicrob Chemother. 2010. PMID: 20576637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters